Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961
Clinical trial NCT02860676 · COMPLETED
Trial details
- NCT number
- NCT02860676
- Sponsor
- University of California, San Diego
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-03
- Primary completion
- 2018-02-27
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.